Abbott Rapid DX North America will produce and supply its BinaxNOW COVID-19 Ag Card in support of the Department of Health and Human Services’ initial requirement for SARS-CoV-2 antigen test kits, the Department of Defense said Wednesday.
The company will conduct work in Florida and Maine, and is expected to complete deliveries under the eight-month contract by the end of October.
The contract has no option periods but has a ceiling value of $766.4 million. It will be funded by HHS’ Office of Assistant Secretary of Health.
BinaxNOW is developed to provide results within 15 minutes. Tens of millions of portable rapid tests are shipped monthly to meet requirements, according to the company.
C5MI has appointed Garth Sanginiti as chief growth officer, the Jacksonville Beach, Florida-based company announced Tuesday. What Will Sanginiti Do as Chief…
SOSi has been awarded a position on a $100 million indefinite-delivery/indefinite-quantity contract to provide strategic and technical services for the Enhanced…
